Animalcare Group Past Earnings Performance
Past criteria checks 1/6
Animalcare Group has been growing earnings at an average annual rate of 65.2%, while the Pharmaceuticals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 0.3% per year. Animalcare Group's return on equity is 1.5%, and it has net margins of 1.6%.
Key information
65.2%
Earnings growth rate
65.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 7.3% |
| Revenue growth rate | 0.3% |
| Return on equity | 1.5% |
| Net Margin | 1.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Animalcare Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 74 | 1 | 35 | 3 |
| 30 Sep 23 | 72 | 1 | 34 | 3 |
| 30 Jun 23 | 70 | 1 | 33 | 3 |
| 31 Mar 23 | 71 | 2 | 33 | 3 |
| 31 Dec 22 | 72 | 2 | 32 | 3 |
| 30 Sep 22 | 72 | 2 | 32 | 3 |
| 30 Jun 22 | 73 | 2 | 31 | 3 |
| 31 Mar 22 | 74 | 1 | 31 | 3 |
| 31 Dec 21 | 74 | 0 | 31 | 3 |
| 30 Sep 21 | 75 | 0 | 31 | 3 |
| 30 Jun 21 | 75 | 0 | 32 | 4 |
| 31 Mar 21 | 73 | 0 | 31 | 4 |
| 31 Dec 20 | 70 | 0 | 30 | 3 |
| 30 Sep 20 | 70 | 0 | 30 | 4 |
| 30 Jun 20 | 70 | 1 | 29 | 4 |
| 31 Mar 20 | 70 | 0 | 29 | 4 |
| 31 Dec 19 | 71 | -1 | 29 | 4 |
| 30 Sep 19 | 72 | -2 | 29 | 4 |
| 30 Jun 19 | 73 | -3 | 29 | 5 |
| 31 Mar 19 | 73 | -1 | 29 | 5 |
| 31 Dec 18 | 72 | 0 | 29 | 5 |
| 30 Sep 18 | 72 | 0 | 30 | 4 |
| 30 Jun 18 | 72 | 0 | 30 | 4 |
| 31 Mar 18 | 67 | 0 | 28 | 3 |
| 31 Dec 17 | 62 | 0 | 26 | 3 |
| 31 Dec 16 | 68 | 4 | 22 | 2 |
| 31 Dec 15 | 47 | -1 | 15 | 1 |
| 31 Dec 14 | 34 | 1 | 8 | 0 |
Quality Earnings: WQ7 has a large one-off loss of £1.2M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: WQ7's current net profit margins (1.6%) are lower than last year (2.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WQ7 has become profitable over the past 5 years, growing earnings by 65.2% per year.
Accelerating Growth: WQ7's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: WQ7 had negative earnings growth (-39%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (1.2%).
Return on Equity
High ROE: WQ7's Return on Equity (1.5%) is considered low.